CSL Ltd. Newsletter
-
MHRA approves CSL’s Andembry to treat angioedema attacks in HAE patients
03 Feb 2025 12:36 GMT
… Regulatory Agency (MHRA) has approved CSL’s Andembry (garadacimab) to … trial, in which the drug reduced HAE attacks rates from … treatment period, and the drug was shown to reduce the … training.
The drug, which will be marketed by the CSL Behring business …
-
AI-Powered Enzyme Engineering Speeds Up Drug Synthesis
31 Jan 2025 14:11 GMT
… terminal CAT-Strep-Linker fusion (CSL-tag) for purification. The DNA … and identified optimized enzymes for pharmaceutical synthesis. The method significantly enhanced … workflow holds potential for broad pharmaceutical and industrial applications.
Journal …
-
Hereditary Angioedema Drug Market Expansion Forecasted at X% CAGR to X Billion USD by 2032 | Argenx, Shire ,CSL Behring
31 Jan 2025 08:08 GMT
… Angioedema Drug Market Include:
BioCryst Pharmaceuticals
Takeda Pharmaceutical Company Limited
Ionis Pharmaceuticals
argenx
Shire
CSL …
-
Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19
31 Jan 2025 08:08 GMT
… and STARR® sa-mRNA drug substance manufacturing.”
About sa … .
About Meiji Seika Pharma
Meiji Seika Pharma, since it launched … #47;)
About CSL Seqirus
CSL Seqirus, a subsidiary of CSL Limited, is … companies. The company provides drug discovery support, as well …
-
Influenza Vaccines Market Global Forecast and Company Analysis 2025-2032, with GlaxoSmithKline, Sanofi, CSL Seqirus, AstraZeneca, Gamma Vaccines, Hualan Bioengineering, Viatris and BioDiem - ResearchAndMarkets.com
29 Jan 2025 13:32 GMT
… the globe. Several worldwide pharmacoeconomic studies have shown that … The US Food and Drug Administration has granted Fast … market.
In July 2024, CSL Seqirus was selected by … Company Analysis
GlaxoSmithKline
Sanofi
CSL Seqirus
AstraZeneca
Gamma Vaccines …
-
Idiopathic Pulmonary Fibrosis Market to Grow Rapidly with New Therapies by 2034, DelveInsight Forecasts
03 Feb 2025 15:06 GMT
… ., Galecto Biotech, Horizon Therapeutics, CSL Behring, Kadmon Corporation, LLCs, … Forecast
Idiopathic Pulmonary Fibrosis Drugs Uptake and Pipeline Development … Therapeutics
• C21 (VP01): Vicore Pharma AB
• Belumosudil (KD025): Kadmon Corporation …
-
Fibrin Sealants Market To Surpass USD 2,561.1 Million By 2032
03 Feb 2025 12:31 GMT
… Players:
•Baxter
•Pfizer Inc.
•Takeda Pharmaceutical Company
•Johnson & Johnson (Ethicon … , Inc.)
•Grifols, S.A.
•CSL Limited
•Vivostat A/S …
-
Influenza Vaccine Market Size to Witness Highest CAGR Forecast by 2022-2033| Emergen Research
03 Feb 2025 11:00 GMT
… plc, AstraZeneca, and CSL Seqirus experiencing a surge … : Hospitals & Retail Pharmacies, Government Suppliers, and Others … France)
AstraZeneca (U.K.)
CSL Limited (Australia)
BIKEN Co …
Hospital & Retail Pharmacies
Government Suppliers
Others
By …
-
Influenza Vaccine Market Set for Rapid Growth, to Hit US$ 13.9 Billion by 2033
31 Jan 2025 12:41 GMT
… S.A., AstraZeneca plc, CSL Limited, BIKEN Co Ltd., GlaxoSmithKline … Inc., Shijiazhuang Yiling Pharmaceutical Co Ltd, BiondVax Pharmaceuticals Ltd., Daiichi … By Distribution Channel
• Hospital Pharmacy & Retail Pharmacy
• Government Suppliers
• Other …
-
Albumin Market To Increase From USD 5.7 Billion In 2023 To USD 9.8 Billion By 2032
30 Jan 2025 07:02 GMT
… in pharmaceutical formulations, including vaccines, medications, and drug delivery systems, enhancing drug stability … Albumin market.
Key Market Players:
•CSL Limited
•Octapharma AG
•Grifols, S …
About
© 1995-2025